Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE)

NCT01380938 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Casa Sollievo della Sofferenza IRCCS

Collaborators